CD276 and neoplasm: In the high-risk group, we observed a substantial upregulation of several immune-suppressive and regulatory molecules, including PD-L1 (CD274), CD276, TIM-3 (HAVCR2), LAG3, and TGFB1, all of which are associated with an immunosuppressive tumor microenvironment.